Hansom Group has jointly invested 120 million Yuan with Wuhan Humanwell Healthcare Group (stock number 600079) to build a broad-spectrum drugs production base in Ethiopia. The company is committed to improving the pharmacy and medical level in Ethiopia, and providing local people with safe, effective and cheap medicine. The project started in the end of 2015.